These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular Williams J; Kerven J; Chen Y; Sagona AP ACS Synth Biol; 2023 Jul; 12(7):2094-2106. PubMed ID: 37318278 [TBL] [Abstract][Full Text] [Related]
6. The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli. Scholl D; Merril C J Bacteriol; 2005 Dec; 187(24):8499-503. PubMed ID: 16321955 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Characterization and In Vivo Efficacy Assessment in Antoine C; Laforêt F; Blasdel B; Fall A; Duprez JN; Mainil J; Delcenserie V; Thiry D Viruses; 2021 Oct; 13(10):. PubMed ID: 34696434 [TBL] [Abstract][Full Text] [Related]
8. Transposable Element Insertions into the Escherichia coli Polysialic Acid Gene Cluster Result in Resistance to the K1F Bacteriophage. Styles KM; Locke RK; Cowley LA; Brown AT; Sagona AP Microbiol Spectr; 2022 Jun; 10(3):e0211221. PubMed ID: 35467398 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554 [TBL] [Abstract][Full Text] [Related]
11. Phage therapy targeting Escherichia coli-a story with no end? Bolocan AS; Callanan J; Forde A; Ross P; Hill C FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27974392 [TBL] [Abstract][Full Text] [Related]
12. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections. Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670 [TBL] [Abstract][Full Text] [Related]
13. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Terwilliger A; Clark J; Karris M; Hernandez-Santos H; Green S; Aslam S; Maresso A Viruses; 2021 Oct; 13(10):. PubMed ID: 34696479 [TBL] [Abstract][Full Text] [Related]
14. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli. Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707 [TBL] [Abstract][Full Text] [Related]
16. Managing urinary tract infections through phage therapy: a novel approach. Malik S; Sidhu PK; Rana JS; Nehra K Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814 [TBL] [Abstract][Full Text] [Related]
17. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related]
18. Use of a Chicken Embryo Lethality Assay to Assess the Efficacy of Phage Therapy. Trotereau A; Schouler C Methods Mol Biol; 2019; 1898():199-205. PubMed ID: 30570735 [TBL] [Abstract][Full Text] [Related]
19. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model. Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758 [No Abstract] [Full Text] [Related]
20. A non-canonical autophagy-dependent role of the ATG16L1 Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]